Ipamorelin - Hubio Pharm

Ipamorelin is a synthetic pentapeptide that selectively activates the ghrelin receptor GHSR-1a, promoting growth hormone release without excess hormonal spillover. Unlike other GH secretagogues, it has minimal adverse effects and limited impact on non-target tissues. Studies show ipamorelin improves gastric motility in postoperative ileus models and causes dose-dependent weight gain in both GH-deficient and normal mice. It increases fat mass and serum leptin levels, suggesting a unique adipogenic profile. Ipamorelin offers a promising alternative to GH therapy in metabolic and hormonal disorders.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Ipamorelin by Hubio Pharm, consult with your doctor or healthcare professional.